ORI Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 13
  • Portfolio
  • 8
  • Exits
  • 3
Exits

ORI Capital General Information

Description

Founded in 2015, ORI Capital is a venture capital firm headquartered in Wanchai, Hong Kong. The firm focuses on investing in innovative companies with disruptive technologies in the healthcare industry globally.

Contact Information

Website
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 4727-34 Sun Hung Kai Centre
  • 30 Harbour Road
  • Wanchai
  • Hong Kong
+852 3898 0000

ORI Capital Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
CG Oncology 10-Dec-2020 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 3 000000 0000
000000 00000000000 10-Mar-2020 00000 00000 000.00 Decision/Risk Analysis Generating Revenue
00 00000000 18-Mar-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 000000 0000
0000000000 0000000 28-Nov-2018 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 1 000000 0000
000000 0000000000 25-Oct-2018 00000 00000 0000 Drug Delivery Generating Revenue 000000 0000
0000000 0000000000 16-Feb-2018 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 000000 0000
00000 000000000000 30-Nov-2017 00000 00000 00000 Drug Discovery Generating Revenue
0000000 03-Nov-2017 00000 00000 000.00 Outcome Management (Healthcare) Generating Revenue
TriSalus Life Sciences 01-Feb-2017 Later Stage VC 000.00 Surgical Devices Generating Revenue 000000 0000
Kymab 24-Nov-2016 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 2 000000 0000
You’re viewing 10 of 13 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ORI Capital Exits (2)

Company Name Exit Date Exit Type Exit Size
Semma Therapeutics 10-Oct-2019 Merger/Acquisition 00000
0000000 0000000000 31-Oct-2018 000 00000
To view ORI Capital’s complete exits history, request access »

ORI Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

ORI Capital Team (7)

Name Title Deals Funds Boards Office
Simone Song Senior Partner & Founder 0 0 0 Wanchai, Hong Kong
Dicky To Partner Wanchai, Hong Kong
Tiffany Liu Financial Controller Wanchai, Hong Kong
Elaine Yang Director 0 0 Wanchai, Hong Kong
James Huang Senior Associate Wanchai, Hong Kong
You’re viewing 5 of 7 team members. Get the full list »

ORI Capital Co-Investors (35)

Name With Exits Lead Partner Series Industry
Cowen Healthcare Investments 2 0 0 Series chart Industry bar
F-Prime Capital 0 0 0 Series chart Industry bar
Temasek Holdings 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 Series chart Industry bar
Eight Roads 0 0 0 Series chart Industry bar
You’re viewing 5 of 35 co-investors. Get the full list »